Progression of diabetic retinopathy in women with pregestational diabetes during pregnancy and postpartum
- PMID: 38895754
- DOI: 10.1111/ceo.14410
Progression of diabetic retinopathy in women with pregestational diabetes during pregnancy and postpartum
Abstract
Background: Diabetic retinopathy (DR) may worsen during pregnancy, but its course in the postpartum remains poorly understood. Understanding the natural history of DR during and after pregnancy can help determine when sight-threatening DR treatment should be administered.
Methods: A prospective longitudinal cohort study recruited pregnant women with pre-existing type 1 (T1D) or type 2 diabetes from two tertiary Diabetes Antenatal Clinics in Melbourne, Australia. Eye examination results in early pregnancy, late pregnancy, and up to 12-months postpartum were compared to determine DR changes. Two-field fundus photographs and optical coherence tomography scans were used to assess DR severity.
Results: Overall, 105 (61.4%) women had at least two eye examinations during the observation period. Mean age was 33.5 years (range 19-51); 54 women (51.4%) had T1D; 63% had HbA1c <7% in early pregnancy. DR progression rate was 23.8% (95% CI 16.4-32.6). Having T1D (RR 4.96, 95% CI 1.83-13.46), pre-existing DR in either eye (RR 4.54, 95% CI 2.39-8.61), and elevated systolic blood pressure (adjusted RR 2.49, 95% CI 1.10-5.66) were associated with increased risk of progression. Sight-threatening progression was observed in 9.5% of women. Among the 19 eyes with progression during pregnancy, 15 eyes remained stable, three eyes progressed, and only one eye regressed in the postpartum.
Conclusions: Nearly 1 in 4 women had DR progression from conception through to 12-months postpartum; almost half of these developing sight-threatening disease. DR progression occurring during pregnancy was found to predominantly remain unchanged, or worsen, after delivery, with very few eyes spontaneously improving postpartum.
Keywords: diabetic retinopathy; pregestational diabetes; pregnancy; progression; risk factors.
© 2024 The Author(s). Clinical & Experimental Ophthalmology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Ophthalmologists.
References
REFERENCES
-
- Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012;60(5):428‐431. doi:10.4103/0301‐4738.100542
-
- Klein BE, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990;13(1):34‐40. doi:10.2337/diacare.13.1.34
-
- Lövestam‐Adrian M, Agardh CD, Aberg A, Agardh E. Pre‐eclampsia is a potent risk factor for deterioration of retinopathy during pregnancy in type 1 diabetic patients. Diabet Med. 1997;14(12):1059‐1065. doi:10.1002/(SICI)1096‐9136(199712)14:12<1059::AID‐DIA505>3.0.CO;2‐8
-
- Galazios G, Papazoglou D, Tsikouras P, Kolios G. Vascular endothelial growth factor gene polymorphisms and pregnancy. J Matern Fetal Neonatal Med. 2009;22(5):371‐378. doi:10.1080/14767050802645035
-
- Choo PP, Md Din N, Azmi N, Bastion MC. Review of the management of sight‐threatening diabetic retinopathy during pregnancy. World J Diabetes. 2021;12(9):1386‐1400. doi:10.4239/wjd.v12.i9.1386
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources